Research Articles from Managed Care

by
Inhaltsverzeichnis Anzeigen

The Cost-Effectiveness of Omega-3 Supplements For Prevention of Secondary Coronary Events

Jordana K. Schmier, MA ; Nancy J. Rachman, PhD ; Michael T. Halpern, MD, PhD

Dietary supplementation with omega-3 fatty acids in U.S. males is associated with fewer cardiovascular fatalities and lower costs

The Cost Benefit to Health Plans of Pharmacotherapy for Alzheimer’s Disease

David S. Geldmacher, MD

As with other chronic diseases of aging, early diagnosis and pharmacologic therapy may reduce the costs for enrollees with Alzheimer’s disease

17 Alpha-Hydroxyprogesterone Caproate (17P) Usage in a Medicaid Managed Care Plan and Reduction in Neonatal Intensive Care Unit Days

Mary V. Mason, MD, MBA ; Kara M. House, BS, MBA ; Cathy M. Fuest, RPh ; Deborah R. Fitzgerald, RN ; Bonnie J. Kitson, MBA

Offering 17P as a benefit to pregnant women enrollees with a history of preterm delivery can reduce NICU days significantly for a Medicaid plan.

Evaluating the Nondrug Costs of Formulary Coverage Restrictions

Paul Abourjaily, PharmD ; William A. Gouveia, MS ; Harry P. Selker, MD, MSPH ; Deborah R. Zucker, MD, PhD

Substantial nondrug costs result from switching prescribed medications in response to changes in insurance coverage, and many nonreimbursed costs shift to providers and patients.

Consumer-Directed Health Plans: Enrollee Views, Early Employer Experience

Janice Frates, PhD ; Ellen Severoni, RN

As CDHPs increasingly penetrate the commercial market , their greatest contribution might lie in funding health services for retirees and in reducing the number of uninsured people by offering affordable insurance.

Clinical and Economic Effects of Coronary Restenosis After Percutaneous Coronary Intervention in a Managed Care Population

Mary Ann Clark, MHA

This study is the first to estimate costs and medical resource use associated with restenosis involving bare metal stents in managed care percutaneous coronary intervention patients.

Managing Drugs for Rare Genetic Diseases: Trends and Insights

Mark Zitter, MBA

This article evaluates recent trends and challenges in health system management of exceedingly rare genetic diseases, from the perspective of the manufacturer, managed care organization, physician, and actuary.

Measuring Outpatient Outcomes of Emesis and Nausea Management in Pregnant Women

David G. Lombardi, MD ; Niki B. Istwan, RN ; Debbie J. Rhea, MPH ; John M. O’Brien, MD ; John R. Barton, MD

In this study, outpatient management was effective in controlling nausea and vomiting during pregnancy and was associated with a reduced need for hospital or emergency room treatment as well as reduced costs.

Evaluating New Therapies for Psoriasis

Thomas Morrow, MD

Along with traditional systemic therapies, the American Academy of Dermatology recommends four biologic agents as first-line treatment for psoriasis patients who are candidates for systemic therapy.

Improving Physician Attendance At Educational Seminars Sponsored By Managed Care Organizations

Michael D. Cabana, MD, MPH ; Randall Brown, MD, MPH ; Noreen M. Clark, PhD ; Diane F. White, RRT ; Juanita Lyons, PhD ; Sylvia Wanner Lang, PhD ; Susan L. Bratton, MD, MPH

Although interactive educational seminars that target physicians require a large investment of resources, they can be cost-effective if medical care is improved as a result.

Pages

more

MANAGED CARE’s Weekly Poll

How will the Supreme Court rule in King v. Burwell?

Any day now, the Supreme Court will hand down its decision. How will the court rule?

In favor of Burwell, upholding the subsidies and leaving the ACA intact
68% (126 votes)
In favor of the plaintiff, King, and against premium subsidies for insurance policies sold on federally facilitated exchanges
32% (58 votes)
Total votes: 184